New anti-tuberculosis drugs and regimens: 2015 update
Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally, 9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. The treatment of MDR/XDR-TB is unfortunately long, toxic and expensive, and the success rate largely unsat...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2015-05-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/1/1/00010-2015.full |